Friday, December 30, 2016

UPDATE 1-Growth hormone deficiency drug from OPKO and Pfizer fails study

Dec 30 (Reuters) - OPKO Health Inc said its

experimental drug for growth hormone deficiency (GHD) in adults

failed to provide a statistically significant benefit over a

placebo in a late-stage study,...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)